Wells Fargo
TSVT

Wells Fargo’s 2seventy bio TSVT Stock Holding History

Wells Fargo’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-30,238
Closed -$149K – 7372
2025
Q1 		$149K Sell
30,238
-2,294
-7% -$7.29K ﹤0.01% 4872
2024
Q4 		$95.6K Buy
32,532
+6,133
+23% +$25.2K ﹤0.01% 5228
2024
Q3 		$125K Buy
26,399
+964
+4% +$4.35K ﹤0.01% 4887
2024
Q2 		$97.9K Buy
25,435
+3,582
+16% +$16.1K ﹤0.01% 4952
2024
Q1 		$117K Buy
21,853
+5,367
+33% +$25.2K ﹤0.01% 4806
2023
Q4 		$70.4K Buy
16,486
+2,738
+20% +$8.42K ﹤0.01% 5113
2023
Q3 		$53.9K Sell
13,748
-45,708
-77% -$300K ﹤0.01% 5138
2023
Q2 		$602K Buy
59,456
+14,017
+31% +$148K ﹤0.01% 3806
2023
Q1 		$463K Buy
45,439
+42,499
+1,446% +$486K ﹤0.01% 3900
2022
Q4 		$27.5K Sell
2,940
-2,174
-43% -$30.7K ﹤0.01% 5127
2022
Q3 		$75K Sell
5,114
-646
-11% -$9.59K ﹤0.01% 4760
2022
Q2 		$77K Sell
5,760
-7,271
-56% -$99.1K ﹤0.01% 4799
2022
Q1 		$222K Sell
13,031
-10,435
-44% -$177K ﹤0.01% 4921
2021
Q4 		$602K Buy
+23,466
New +$732K ﹤0.01% 4518

Other funds holding TSVT

N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Wells Fargo's TSVT Position: Q2 2025 in Review

Wells Fargo sold out of 2seventy bio (TSVT) in Q2 2025, closing a stake of 30,238 shares — an estimated $149K sold.

Wells Fargo first reported a position in TSVT in Q4 2021 and held it in 14 quarters. The position peaked at $602K in Q4 2021. 2 funds tracked by Wall St. Rank hold TSVT as of Q2 2025.

  • Wells Fargo reported no remaining 2seventy bio position as of Q2 2025 after selling out during the quarter.
  • Wells Fargo sold 30,238 2seventy bio shares in Q2 2025, an estimated $149K.
  • Wells Fargo first reported a position in 2seventy bio in Q4 2021 and held it in 14 quarters.
  • Wells Fargo's 2seventy bio position peaked at $602K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2025.

Based on Wells Fargo's 13F filing for Q2 2025, filed 14 Aug 2025.